Soreide Law Group is investigating claims on behalf of UBS investors who have sustained losses investing in UBS Yield Optimization Notes. Yield Optimization Notes, otherwise known as reverse convertibles, are complex structured products with substantial risk. Reverse convertibles are the subject of multiple regulatory investigations. Upon information and belief, UBS did not require option suitability approval for Yield Optimization Note clients. UBS Yield Optimization Notes purchasers were buying the equivalent of a short put transaction. UBS marketed these products on certain volatile stocks that have suffered substantial declines including Micron, RIMM, US Steel, First Solar, and others including structured products such as UBS 100% principal protection notes, UBS Yield Optimization Notes with Contingent Protection, UBS Bullish Underlying Linked Securities (UBS BULS), and UBS Enhanced Appreciation Securities (UBS EAS).
If you have experienced financial losses from investing in UBS Yield Optimization Notes or another reverse convertible product, call Securities Lawyer, Lars Soreide, of the Soreide Law Group, at 888-760-6552 for a free consultation or visit our website at www.securitieslawyer.com.
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.